Variations of serum IgG subclass levels in hepatitis C virus infection during interferon-alpha therapy

被引：5

作者：

Musset, L

Ghillani, P

Lunel, F

Cacoub, P

Cresta, P

Frangeul, L

Rosenheim, M

Preudhomme, JL

机构：

[1] GRP HOSP PITIE SALPETRIERE,VIROL LAB,F-75651 PARIS 13,FRANCE

[2] GRP HOSP PITIE SALPETRIERE,DEPT HEPATOGASTROENTEROL,F-75651 PARIS 13,FRANCE

[3] GRP HOSP PITIE SALPETRIERE,DEPT INTERNAL MED,F-75651 PARIS 13,FRANCE

[4] GRP HOSP PITIE SALPETRIERE,PUBL HLTH UNIT,F-75651 PARIS 13,FRANCE

[5] UNIV POITIERS HOSP,LAB IMMUNOL & IMMUNOPATHOL,CNRS URA 1172,POITIERS,FRANCE

来源：

IMMUNOLOGY LETTERS | 1997年 / 55卷 / 01期

关键词：

hepatitis C virus; IgG subclass; interferon-alpha;

D O I：

10.1016/S0165-2478(96)02681-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Serum IgG1 levels are selectively increased in patients with chronic hepatitis C virus (HCV) infection. In 15 patients who received interferon (IFN)-alpha therapy, serum levels of immunoglobulin classes and IgG subclasses were measured during treatment and after it was discontinued. In spite of important individual variations, mean IgG, IgG1, IgA and IgM levels decreased during therapy and tended to return to pre-treatment levels afterwards, with no detectable correlation with clinical and biological parameters. These results suggest an effect of IFN-alpha on in vivo immunoglobulin production, in HCV carriers. (C) 1997 Elsevier Science B.V.

引用

页码：41 / 45

页数：5

共 50 条

[41] Transcriptional response to hepatitis C virus infection and interferon-alpha treatment in the human liver
Boldanova, Tujana
Suslov, Aleksei
Heim, Markus H.
Necsulea, Anamaria
EMBO MOLECULAR MEDICINE, 2017, 9 (06) : 816 - 834
[42] INTERFERON-ALPHA AND PSORIASIS - VARIATIONS IN SERUM INTERFERON-ALPHA CONCENTRATIONS DURING THE COURSE OF PSORIASIS-TREATMENT
RUFFAULT, A
PIBOUIN, M
SANDRON, A
DUVAIL, C
HUGHES, L
CHEVRANTBRETON, J
FAUCONNIER, B
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1988, 115 (09): : 985 - 985
[43] Hyperglycemia and insulin resistance in patients with chronic hepatitis C virus infection: Effects of interferon-alpha therapy.
Ismaeil, A
Abdelrahman, Y
Abdel-Hady, AA
Abou-Zekri, N
Allam, MN
Hassanien, H
HEPATOLOGY, 2000, 32 (04) : 369A - 369A
[44] Comparison of histological response with biochemical and virological response to interferon-alpha therapy in chronic hepatitis C virus infection
McMahon, RFT
McLindon, JP
Houghton, D
Christopher, J
Craske, J
Warnes, TW
JOURNAL OF PATHOLOGY, 1996, 179 : A9 - A9
[45] Interferon-Alpha Therapy in Patients with Hepatitis C Virus Infection Increases Plasma Phenylalanine and the Phenylalanine to Tyrosine Ratio
Zoller, Heinz
Schloegl, Anna
Schroecksnadel, Sebastian
Vogel, Wolfgang
Fuchs, Dietmar
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2012, 32 (05): : 216 - 220
[46] SERUM ANTI-C100-3 AS A USEFUL INDICATOR PREDICTIVE OF RESPONSE TO INTERFERON-ALPHA THERAPY IN CHRONIC HEPATITIS VIRUS-C INFECTION
MATSUO, S
FUJIWARA, K
HEPATOLOGY, 1994, 20 (04) : A374 - A374
[47] Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C.
Hasegawa, I
Orito, E
Tanaka, Y
Hirashima, N
Sakakibara, K
Ohno, T
Sugauchi, F
Suzuki, S
Sakurai, M
Fujiwara, K
Ozasa, T
Ueda, R
Mizokami, M
HEPATOLOGY, 2002, 36 (04) : 369A - 369A
[48] Effect of Interferon-Alpha Therapy on Hepatitis D Virus Reply
Guedj, Jeremie
Canini, Laetitia
Cotler, Scott J.
Dahari, Harel
HEPATOLOGY, 2015, 61 (06) : 2118 - 2119
[49] Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C
Ueno, T
Inuzuka, S
Sata, M
Koh, H
Tamaki, S
Kin, M
Sugawara, H
Sakata, R
Torimura, T
Tanikawa, K
HEPATO-GASTROENTEROLOGY, 1995, 42 (05) : 522 - 527
[50] APPROPRIATE INTERFERON-ALPHA THERAPY FOR CHRONIC HEPATITIS-C - AN ASSESSMENT BY QUANTITATIVE CHANGES IN SERUM HEPATITIS-C VIRUS-RNA
WATANABE, S
KOBAYASHI, Y
KONISHI, M
YOKOI, M
KAKEHASHI, R
KAITO, M
SUZUKI, S
INTERNAL MEDICINE, 1993, 32 (07) : 523 - 529

← 1 2 3 4 5 →